Nevakar Inc. Announces Formation Of Nevakar Injectables
Share this article Share this article BRIDGEWATER, N.J., May 25, 2021 /PRNewswire/ -- Nevakar Inc. ("Nevakar"), a privately held biopharmaceutical company, today announces the establishment of Nevakar Injectables Inc., a newly formed company with an established portfolio of products focused on critical patient care, acute pain management, long acting injectables and hospital infections. At inception Nevakar Injectables will operate as a wholly owned subsidiary of Nevakar Inc. Nevakar Injectables launches with 13 active programs, three of which have been filed with FDA under the 505(b)(2) reg...